Effect of Ischemia-Reperfusion on the Incidence of Acute Cellular Rejection and Timing of Histologic Hepatitis C Virus Recurrence After Liver Transplantation

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1504-1510

  Killackey, M T ^a   Gondolesi, G E ^a   Liu, L U ^a   Paramesh, A S ^a   Thung, S N ^a   Suriawinata, A ^a   Nguyen, E ^a   Roayaie, S ^a   Schwartz, M E ^a   Emre, S ^b   Schiano, T D ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HYPERTENSIVE AGENT; METHYLPREDNISOLONE;

ACUTE GRAFT REJECTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CADAVER DONOR; DRUG DOSE REDUCTION; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; ISCHEMIA; KAPLAN MEIER METHOD; LIVER HISTOLOGY; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT VIRUS INFECTION; REPERFUSION INJURY; RETRANSPLANTATION; STATISTICAL ANALYSIS;

ACUTE DISEASE; ADULT; ALANINE TRANSAMINASE; GRAFT REJECTION; HEPATITIS C; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REOPERATION; REPERFUSION INJURY; RETROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 45449105568     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.101     Document Type: Article

References (39)

1. Busuttil R.W., and Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 9 (2003) 651
2. Ploeg R.J., D'Alessandro A.M., Knechtle S.J., et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 55 (1993) 807
3. Briceno J., Marchal T., Padillo J., et al. Influence of marginal donors on liver preservation injury. Transplanation 74 (2002) 522
4. Brokelman W., Stel A.L., and Ploeg R.J. Risk factors for primary dysfunction after liver transplantation in the University of Wisconsin solution era. Transplant Proc 31 (1999) 2087
5. Howard T.K., Klintmalm G.B.G., Cofer J.B., et al. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 49 (1990) 103
6. Katz E., Mor E., Schwartz M.E., et al. Preservation injury in clinical liver transplantation: Incidence and effect on rejection and survival. Clin Transplant 8 (1994) 492
7. Shackleton C.R., Martin P., Melinek J., et al. Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. Transplantation 60 (1995) 554
8. Bao Y.M., Adam R., Samuel D., Castaing D., and Bismuth H. Influence of high aminotransferase levels on rejection in liver transplantation. Transplant Proc 26 (1994) 259-260 1994
9. Bao Y.M., Adam R., Farges O., et al. Impact of preservation-induced liver injury on the risk of rejection of rat and human liver grafts. Transplant Proc 27 (1995) 2502
10. Pirenne J., Gunson B., Khaleef H., et al. Influence of ischemia-reperfusion injury on rejection after liver transplantation. Transplant Proc 29 (1997) 366
11. Katz E., Mor E., Patel T., et al. Association between preservation injury and early rejection in clinical liver transplantation: fact or myth?. Transplant Proc 25 (1993) 1907
12. Maluf D.G., Stravitz R.T., Cotterell A.H., et al. Adult living donor versus deceased donor liver transplantation: a 6-year single center experience. Am J Transplant 5 (2005) 149
13. Fan S., and Zhang Z. Comparison of acute cellular rejection between living donor liver transplantation and cadaveric liver transplantation. Zhonghua Yi Xue Za Zhi 81 (2001) 1092
14. Miller C.M., Gondolesi G.E., Florman S., et al. One hundred nine living donor liver transplants in adults and children: a single center experience. Ann Surg 234 (2001) 301
15. Levy A.E., Perkins J.D., Larson A., et al. Early peri-transplant hepatocellular injury may lead to more aggressive hepatitis C recurrence at one year. Hepatology 36A (2002) X
16. Sheiner P.A., Schwartz M.E., Mor E., et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 21 (1995) 30
17. Tisone G., Laria G., Orlando G., et al. Effect of steroid amount on hepatitis C recurrence following orthotopic liver transplantation. Transplant Proc 31 (1999) 3167
18. Ghobrial R.M., Amersi F., Farmer D.G., et al. Rapid and severe early HCV recurrence following adult living donor liver transplantation. Am J Transplant 2 (2002) 163A
19. Garcia-Retortillo M., Forns X., Llovet J.M., et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 40 (2004) 699
20. Shiffman M.L., Stravitz R.T., Contos M.J., et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 10 (2004) 1248
21. Russo M.W., Galanko J., Beavers K., et al. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 10 (2004) 340
22. Maruyama H., Harada A., Kurokawa T., et al. Duration of liver ischemia and hepatic regeneration after hepatectomy in rats. J Surg Res 58 (1995) 290
23. Berenguer M., Prieto M., Cordoba J., et al. Early development of chronic active hepatitis in recurrent hepatitis C after liver transplantation: association with treatment of rejection. J Hepatol 28 (1998) 756
24. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 25 (1997) 658
25. Neil D.A.H., Hubscher S.G., et al. Are parenchymal changes in early post-transplant biopsies related to preservation-reperfusion injury or rejection?. Transplantation 71 (2001) 1566
26. Kakizoe S., Yanaga K., and Starzl T.E. Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology 11 (1990) 932
27. McKeown C.M., Edwards V., and Phillips M.J. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation 46 (1988) 178
28. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284 (2003) G15
29. Serracino-Inglott F., Habib N.A., and Mathie R.T. Hepatic ischemia-reperfusion injury. Am J Surg 181 (2001) 160
30. Fondevila C., Busuttil R.W., and Kupiec-Weglinski J.W. Hepatic ischemia/reperfusion injury-a fresh look. Exp Molec Pathol 74 (2003) 86
31. Shah V., and Kamath P.S. Nitric oxide in liver transplantation: pathobiology and clinical implications. Liver Transpl 9 (2003) 1
32. Ohkohchi N. Mechanisms of preservation and ischemic/reperfusion injury in liver transplantation. Transplant Proc 34 (2002) 2670
33. Schemmer P., Mehrabi A., Kraus T., et al. New aspects on reperfusion injury to liver-impact of organ harvest. Nephrol Dial Transplant 19 (2004) 26
34. Oltoff K.M. Molecular pathways of regeneration and repair after liver transplantation. World J Surg 26 (2002) 831
35. Bartlett A.S., Ramadas R., Furness S., et al. The natural history of acute histologic rejection without biochemical graft dysfunction in orthotopic liver transplantation: a systematic review. Liver Transpl 8 (2002) 1147
36. Gane E.J., Naoumov N.V., Qian K.P., et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 110 (1996) 167
37. Boker K.H.W., Dalley G., Bahr M.J., et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 25 (1997) 203
38. Baron P.W., Sindram D., Higdon D., et al. Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation. Liver Transpl 6 (2000) 407
39. Clavien P.A., Harvey P.R., and Strasberg S.M. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 53 (1992) 957